Aren’t the vaccines experimental drugs? Shouldn’t someone with sickle cell disease wait for a few years before they receive it after all the side effects from the vaccine have been sorted out?

Vaccination is strongly recommended for persons with sickle cell disease.
Normally, companies wait to invest in the mass production of vaccines until clinical trials have shown them to be safe and effective; doing otherwise poses a large financial risk. In the case of COVID-19 vaccine development, however, governments largely assumed that financial risk to decrease the wait before mass vaccination campaigns could begin. As a result, when the clinical trials of the vaccines available in Canada showed they were safe and effective, there was a very little delay before mass production could start.

Nonetheless, we still have the assurance that the tens of thousands of people who participated in the clinical trials, as well as the many millions of people who went on to have the vaccines outside of the clinical trials, haven’t suffered from very adverse reactions. This includes patients with sickle cell disease. At this point, waiting any longer before receiving the vaccine is unlikely to reveal any new information about side effects and will only increase the risk of developing COVID-19, which is many times more dangerous, both to you and to the friends, family, and co-workers you might spread it to.

Watch – How were the vaccines developed so quickly?

Read – DPH_CovidVaccine_How_2-4-21.indd (ct.gov)